CN103750339A - 雪莲培养物保健食品及其用途 - Google Patents
雪莲培养物保健食品及其用途 Download PDFInfo
- Publication number
- CN103750339A CN103750339A CN201410008936.9A CN201410008936A CN103750339A CN 103750339 A CN103750339 A CN 103750339A CN 201410008936 A CN201410008936 A CN 201410008936A CN 103750339 A CN103750339 A CN 103750339A
- Authority
- CN
- China
- Prior art keywords
- saussurea involucrata
- involucrata culture
- health food
- radiation
- health
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000013305 food Nutrition 0.000 title abstract description 15
- 241000133134 Saussurea Species 0.000 title abstract description 7
- 230000005855 radiation Effects 0.000 claims abstract description 52
- 239000000284 extract Substances 0.000 claims abstract description 44
- 230000002929 anti-fatigue Effects 0.000 claims abstract description 23
- 239000000463 material Substances 0.000 claims abstract description 10
- 241001145025 Saussurea involucrata Species 0.000 claims description 104
- 235000013402 health food Nutrition 0.000 claims description 51
- 241001165494 Rhodiola Species 0.000 claims description 33
- 238000000034 method Methods 0.000 claims description 19
- 238000002360 preparation method Methods 0.000 claims description 14
- 239000000843 powder Substances 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 229930003944 flavone Natural products 0.000 claims description 10
- 235000011949 flavones Nutrition 0.000 claims description 10
- 239000000469 ethanolic extract Substances 0.000 claims description 9
- 239000012141 concentrate Substances 0.000 claims description 7
- 150000002213 flavones Chemical class 0.000 claims description 7
- 235000012054 meals Nutrition 0.000 claims description 6
- 239000007921 spray Substances 0.000 claims description 6
- 238000005507 spraying Methods 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- ILRCGYURZSFMEG-UHFFFAOYSA-N Salidroside Natural products OC1C(O)C(O)C(CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-UHFFFAOYSA-N 0.000 claims description 5
- ILRCGYURZSFMEG-RQICVUQASA-N salidroside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-RQICVUQASA-N 0.000 claims description 5
- -1 vina Substances 0.000 claims description 5
- 238000005516 engineering process Methods 0.000 claims description 4
- 238000004108 freeze drying Methods 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- 238000010792 warming Methods 0.000 claims description 3
- 235000009508 confectionery Nutrition 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 239000006071 cream Substances 0.000 claims 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims 1
- 239000007887 hard shell capsule Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 239000007901 soft capsule Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 31
- 244000042430 Rhodiola rosea Species 0.000 abstract description 5
- 235000003713 Rhodiola rosea Nutrition 0.000 abstract description 5
- 241000196324 Embryophyta Species 0.000 abstract description 4
- 235000013376 functional food Nutrition 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 4
- 230000003471 anti-radiation Effects 0.000 abstract description 2
- 239000005417 food ingredient Substances 0.000 abstract description 2
- 230000005802 health problem Effects 0.000 abstract description 2
- 238000012360 testing method Methods 0.000 description 38
- 229920002527 Glycogen Polymers 0.000 description 32
- 229940096919 glycogen Drugs 0.000 description 32
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 30
- 230000002440 hepatic effect Effects 0.000 description 25
- 241000699666 Mus <mouse, genus> Species 0.000 description 24
- 206010016256 fatigue Diseases 0.000 description 24
- 230000009182 swimming Effects 0.000 description 21
- 241000699670 Mus sp. Species 0.000 description 17
- 210000003205 muscle Anatomy 0.000 description 17
- 238000011160 research Methods 0.000 description 17
- 210000002966 serum Anatomy 0.000 description 17
- 239000004310 lactic acid Substances 0.000 description 15
- 235000014655 lactic acid Nutrition 0.000 description 15
- ILRCGYURZSFMEG-RKQHYHRCSA-N Salidroside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OCCC1=CC=C(O)C=C1 ILRCGYURZSFMEG-RKQHYHRCSA-N 0.000 description 14
- 230000006378 damage Effects 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 13
- 239000008280 blood Substances 0.000 description 13
- 210000000265 leukocyte Anatomy 0.000 description 13
- 239000003795 chemical substances by application Substances 0.000 description 12
- 230000006870 function Effects 0.000 description 12
- 238000003304 gavage Methods 0.000 description 12
- 241000700159 Rattus Species 0.000 description 11
- 239000003814 drug Substances 0.000 description 11
- 208000019155 Radiation injury Diseases 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 9
- 239000002775 capsule Substances 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 230000003203 everyday effect Effects 0.000 description 8
- 230000004083 survival effect Effects 0.000 description 8
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 7
- 239000004202 carbamide Substances 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 230000001681 protective effect Effects 0.000 description 7
- 210000002798 bone marrow cell Anatomy 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 230000036541 health Effects 0.000 description 5
- 230000033001 locomotion Effects 0.000 description 5
- 239000011812 mixed powder Substances 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 102000019197 Superoxide Dismutase Human genes 0.000 description 4
- 108010012715 Superoxide dismutase Proteins 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 235000008504 concentrate Nutrition 0.000 description 4
- 210000004748 cultured cell Anatomy 0.000 description 4
- 230000034994 death Effects 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 238000010172 mouse model Methods 0.000 description 4
- 210000005259 peripheral blood Anatomy 0.000 description 4
- 239000011886 peripheral blood Substances 0.000 description 4
- 230000002093 peripheral effect Effects 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 238000012449 Kunming mouse Methods 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- PPCUPSGMDOTIMV-UHFFFAOYSA-N Sachalin Natural products CC1=C/C2OC(=O)C(=C)C2C(O)CC(=C)C(O)CC1 PPCUPSGMDOTIMV-UHFFFAOYSA-N 0.000 description 3
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 3
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 210000005096 hematological system Anatomy 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 230000001678 irradiating effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 3
- 230000003442 weekly effect Effects 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000011132 hemopoiesis Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 150000004804 polysaccharides Chemical class 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 210000004994 reproductive system Anatomy 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 210000001541 thymus gland Anatomy 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 240000001592 Amaranthus caudatus Species 0.000 description 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 206010065369 Burnout syndrome Diseases 0.000 description 1
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 241000723353 Chrysanthemum Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013183 Dislocation of vertebra Diseases 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 101100460719 Mus musculus Noto gene Proteins 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 241000233805 Phoenix Species 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 244000061458 Solanum melongena Species 0.000 description 1
- 206010064127 Solar lentigo Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 231100000644 Toxic injury Toxicity 0.000 description 1
- 238000008083 Urea Assay Methods 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000003905 agrochemical Substances 0.000 description 1
- 238000004378 air conditioning Methods 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 239000004178 amaranth Substances 0.000 description 1
- 235000012735 amaranth Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000496 anti-anoxic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000008482 dysregulation Effects 0.000 description 1
- 230000005670 electromagnetic radiation Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 235000021393 food security Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 230000005251 gamma ray Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000007674 genetic toxicity Effects 0.000 description 1
- 231100000025 genetic toxicology Toxicity 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000004579 marble Substances 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 231100000682 maximum tolerated dose Toxicity 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 238000000874 microwave-assisted extraction Methods 0.000 description 1
- 238000003032 molecular docking Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000033116 oxidation-reduction process Effects 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000644 propagated effect Effects 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 238000009781 safety test method Methods 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 230000025366 tissue development Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 230000004393 visual impairment Effects 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/40—Shaping or working of foodstuffs characterised by the products free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Botany (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别及剂量 | 辐射前(×109/L) | 辐射后14d(×109/L) |
辐射对照组 | 12.04±2.73 | 5.55±1.29 |
雪莲培养物对比组 | 11.93±2.50 | 6.44±1.29 |
红景天提取物对比组 | 11.76±2.43 | 6.31±1.57 |
实施例3实验组 | 11.86±2.78 | 7.61±1.31 |
实施例4实验组 | 11.98±2.36 | 7.96±1.66 |
组别及剂量 | 微核数(个) | 骨髓细胞微核率(‰) |
辐射对照组 | 14.7±3.72 | 14.7 |
雪莲培养物对比组 | 13.4±2.32 | 13.4 |
红景天提取物对比组 | 13.1±3.32 | 13.1 |
实施例3实验组 | 12.1±3.34 | 12.1 |
实施例4实验组 | 11.5±2.64 | 11.5 |
组别 | 游泳时间(min) | 血清尿素(mmol/L) | 肝糖原含量(mg/100g肝组织) |
对照组 | 32.00±9.57 | 6.38±0.76 | 6463.97±762.35 |
雪莲培养物对比组 | 36.21±4.56 | 6.01±0.73 | 7653.75±351.35 |
红景天提取物对比组 | 35.62±7.06 | 5.90±0.71 | 7490.19±289.36 |
实施例3实验组 | 40.14±5.32 | 5.60±0.89 | 9096.07±304.55 |
实施例4实验组 | 44.70±5.85 | 5.33±0.69 | 9686.03±2767.57 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410008936.9A CN103750339B (zh) | 2014-01-08 | 2014-01-08 | 雪莲培养物保健食品及其用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410008936.9A CN103750339B (zh) | 2014-01-08 | 2014-01-08 | 雪莲培养物保健食品及其用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103750339A true CN103750339A (zh) | 2014-04-30 |
CN103750339B CN103750339B (zh) | 2016-06-15 |
Family
ID=50517792
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410008936.9A Active CN103750339B (zh) | 2014-01-08 | 2014-01-08 | 雪莲培养物保健食品及其用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103750339B (zh) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105998280A (zh) * | 2016-04-28 | 2016-10-12 | 张雅萍 | 一种抗霾药食两用虫草雪莲组合物及其制备方法与应用 |
CN106260359A (zh) * | 2016-09-18 | 2017-01-04 | 大连普瑞康生物技术有限公司 | 一种雪莲培养物组合物灵芝茶及其制备方法 |
CN106490259A (zh) * | 2016-10-10 | 2017-03-15 | 大连工业大学 | 一种具有抗辐射功能的天山雪莲茶及其制备方法 |
CN107242561A (zh) * | 2017-02-24 | 2017-10-13 | 北京众康生物科技有限公司 | 一种雪莲西洋参马鹿茸胶囊及其制备方法 |
CN108552532A (zh) * | 2018-03-15 | 2018-09-21 | 北京瑞德伦医药科技有限公司 | 一种天麻雪莲培养物组合物及制备方法 |
CN108813610A (zh) * | 2018-05-30 | 2018-11-16 | 南京中生生物科技有限公司 | 一种用于提高免疫力的雪莲组合物及其应用 |
CN109419001A (zh) * | 2017-09-03 | 2019-03-05 | 大德仟年生物技术有限公司 | 免疫灵胶囊及其制备方法 |
CN110652006A (zh) * | 2019-10-12 | 2020-01-07 | 神威药业集团有限公司 | 一种缓解体力疲劳的组合物及其制备方法 |
CN112263604A (zh) * | 2020-11-12 | 2021-01-26 | 成都武侯甘露海藏医院有限公司 | 一种藏药五味甘露组合物及其制备方法与应用 |
CN113052202A (zh) * | 2021-01-29 | 2021-06-29 | 昆明理工大学 | 一种用于分类全日面图像中太阳黑子群的方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1208585A (zh) * | 1998-05-29 | 1999-02-24 | 刘作纪 | 雪莲花茶、冰茶及其制备方法 |
CN101856119A (zh) * | 2010-03-23 | 2010-10-13 | 无锡市天赐康生物科技有限公司 | 一种缓解体力疲劳抗辐射危害的保健食品及其制备方法 |
-
2014
- 2014-01-08 CN CN201410008936.9A patent/CN103750339B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1208585A (zh) * | 1998-05-29 | 1999-02-24 | 刘作纪 | 雪莲花茶、冰茶及其制备方法 |
CN101856119A (zh) * | 2010-03-23 | 2010-10-13 | 无锡市天赐康生物科技有限公司 | 一种缓解体力疲劳抗辐射危害的保健食品及其制备方法 |
Non-Patent Citations (3)
Title |
---|
张清华等: "《中医中药与养生(第1版)》", 31 March 2007, article "单味抗衰老中药有哪些", pages: 211-212 - 226 * |
薛秀峰等: "注射用冻干雪莲的制备工艺及质量研究", 《中国药房》, vol. 16, no. 8, 31 December 2005 (2005-12-31), pages 635 - 637 * |
赵晓玫等: "天山雪莲培养物的抗辐射作用研究", 《中外医疗》, no. 6, 31 December 2012 (2012-12-31), pages 26 * |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105998280A (zh) * | 2016-04-28 | 2016-10-12 | 张雅萍 | 一种抗霾药食两用虫草雪莲组合物及其制备方法与应用 |
CN106260359A (zh) * | 2016-09-18 | 2017-01-04 | 大连普瑞康生物技术有限公司 | 一种雪莲培养物组合物灵芝茶及其制备方法 |
CN106490259A (zh) * | 2016-10-10 | 2017-03-15 | 大连工业大学 | 一种具有抗辐射功能的天山雪莲茶及其制备方法 |
CN107242561A (zh) * | 2017-02-24 | 2017-10-13 | 北京众康生物科技有限公司 | 一种雪莲西洋参马鹿茸胶囊及其制备方法 |
CN109419001A (zh) * | 2017-09-03 | 2019-03-05 | 大德仟年生物技术有限公司 | 免疫灵胶囊及其制备方法 |
CN108552532A (zh) * | 2018-03-15 | 2018-09-21 | 北京瑞德伦医药科技有限公司 | 一种天麻雪莲培养物组合物及制备方法 |
CN108813610A (zh) * | 2018-05-30 | 2018-11-16 | 南京中生生物科技有限公司 | 一种用于提高免疫力的雪莲组合物及其应用 |
CN108813610B (zh) * | 2018-05-30 | 2022-03-04 | 南京中生生物科技有限公司 | 一种用于提高免疫力的雪莲组合物及其应用 |
CN110652006A (zh) * | 2019-10-12 | 2020-01-07 | 神威药业集团有限公司 | 一种缓解体力疲劳的组合物及其制备方法 |
CN112263604A (zh) * | 2020-11-12 | 2021-01-26 | 成都武侯甘露海藏医院有限公司 | 一种藏药五味甘露组合物及其制备方法与应用 |
CN113052202A (zh) * | 2021-01-29 | 2021-06-29 | 昆明理工大学 | 一种用于分类全日面图像中太阳黑子群的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103750339B (zh) | 2016-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103750339B (zh) | 雪莲培养物保健食品及其用途 | |
CN102845637B (zh) | 一种防治禽流感的鸡饲料及其中药添加剂 | |
CN107691952A (zh) | 一种抗运动性疲劳、促进运动后恢复的组合物及其制备方法 | |
CN102172269B (zh) | 一种具有美容作用阿胶组合食品 | |
CN101518336A (zh) | 一种具有抗氧化功能的营养食品及其制备方法 | |
CN103478508B (zh) | 用于提高鸡免疫力的中药组合物、饲料及其制备方法 | |
CN101579120A (zh) | 一种具有减肥功能的营养食品及其制备方法 | |
CN105231051A (zh) | 用于提高猪肉肉质风味的育肥猪用饲料及其制备方法 | |
CN105231050A (zh) | 一种用于提高猪肉肉质风味的育肥猪用饲料添加剂及其制备方法 | |
CN102600212A (zh) | 一种增强免疫力、辅助治疗肿瘤的医药保健品 | |
CN107373672A (zh) | 一种月经不调女性专用型临床营养配方及其制备方法 | |
CN104799286B (zh) | 一种用于提高免疫力的组合物及其制备方法 | |
CN105285400A (zh) | 用于提高猪肉肉质风味的育肥猪用饲料添加剂及其制备方法 | |
CN104351612A (zh) | 一种海参灵芝葡聚糖硒制剂及其制备方法 | |
CN107048386A (zh) | 一种性功能调节保健食品 | |
CN102579514A (zh) | 一种八角枫的炮制方法 | |
CN101904917A (zh) | 用于排铅的药物组合物及其制备方法 | |
CN101904501B (zh) | 一种缓解疲劳的功能食品及其制备方法 | |
CN102552645B (zh) | 一种补肾壮阳保健药物及其制备方法 | |
CN105230973A (zh) | 一种育肥猪饲料及其制备方法 | |
CN102631409B (zh) | 一种增强免疫力、缓解体力疲劳、抗肿瘤功能的保健药物 | |
CN106389477B (zh) | 一种土生戈登氏菌的全细胞植物油提取物的制备方法和应用 | |
CN104799289A (zh) | 具有抗肿瘤提高免疫功能的复合营养食品及其生产方法 | |
CN103181557A (zh) | 具有减肥功能的营养食品及其制备方法 | |
CN101797280B (zh) | 一种防衰老的中药制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Cultivation and health food of Saussurea involucrata Effective date of registration: 20200930 Granted publication date: 20160615 Pledgee: Dalian Xigang District Enterprise Credit Financing Guarantee Co., Ltd Pledgor: DALIAN PRACTICAL BIOTECHNOLOGY Co.,Ltd. Registration number: Y2020210000054 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210929 Granted publication date: 20160615 Pledgee: Dalian Xigang District Enterprise Credit Financing Guarantee Co., Ltd Pledgor: DALIAN PRACTICAL BIOTECHNOLOGY Co.,Ltd. Registration number: Y2020210000054 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |